Browse By: Country ι Category ι Latest Reports ι Tag
Home  »  Global Markets Direct

Global Markets Direct Market Research Reports

Global Markets Direct is a leading provider of global business intelligence and market analysis. The company publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. With a large dedicated research and analysis capability, Global Markets Direct employs rigorous primary and secondary research techniques in developing unique data sets and research materials.

At the heart of Global Markets Direct are unique databases, updated live, covering millions of rows of key information for the studied industry at a global level.

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015
Global Markets Directs, B-Cell Non-Hodgkin Lymphoma Pipeline Review, H1 2015, provides an overview of the B-Cell Non-Hodgkin Lymphomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for B-Cell Non-Hodgkin Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for B-Cell Non-Hodgkin Lymphoma and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,00
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H1 2015
Global Markets Directs, Gastroesophageal (GE) Junction Carcinomas Pipeline Review, H1 2015, provides an overview of the Gastroesophageal (GE) Junction Carcinomass therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Gastroesophageal (GE) Junction Carcinomas, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Gastroesophageal (GE) Junction Carcinomas and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from acr
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Restenosis - Pipeline Review, H1 2015
Global Markets Directs, Restenosis Pipeline Review, H1 2015, provides an overview of the Restenosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Restenosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Restenosis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information source
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Tinnitus - Pipeline Review, H1 2015
Global Markets Directs, Tinnitus Pipeline Review, H1 2015, provides an overview of the Tinnituss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Tinnitus, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Tinnitus and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from G
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Fabry Disease - Pipeline Review, H1 2015
Global Markets Directs, Fabry Disease Pipeline Review, H1 2015, provides an overview of the Fabry Diseases therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Fabry Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Fabry Disease and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and inform
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2015
Global Markets Directs, Chemotherapy Induced Peripheral Neuropathy Pipeline Review, H1 2015, provides an overview of the Chemotherapy Induced Peripheral Neuropathys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chemotherapy Induced Peripheral Neuropathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chemotherapy Induced Peripheral Neuropathy and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
African Trypanosomiasis - Pipeline Review, H1 2015
Global Markets Directs, African Trypanosomiasis Pipeline Review, H1 2015, provides an overview of the African Trypanosomiasiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for African Trypanosomiasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for African Trypanosomiasis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. T
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Chemotherapy Induced Anemia - Pipeline Review, H1 2015
Global Markets Directs, Chemotherapy Induced Anemia Pipeline Review, H1 2015, provides an overview of the Chemotherapy Induced Anemias therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chemotherapy Induced Anemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chemotherapy Induced Anemia and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,00
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Arterial Thrombosis - Pipeline Review, H1 2015
Global Markets Directs, Arterial Thrombosis Pipeline Review, H1 2015, provides an overview of the Arterial Thrombosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Arterial Thrombosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Arterial Thrombosis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is bui
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Grass Pollen Allergy - Pipeline Review, H1 2015
Global Markets Directs, Grass Pollen Allergy Pipeline Review, H1 2015, provides an overview of the Grass Pollen Allergys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Grass Pollen Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Grass Pollen Allergy and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Periodontitis - Pipeline Review, H1 2015
Global Markets Directs, Periodontitis Pipeline Review, H1 2015, provides an overview of the Periodontitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Periodontitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Periodontitis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and inform
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2015
Global Markets Directs, Metastatic Hepatocellular Carcinoma (HCC) Pipeline Review, H1 2015, provides an overview of the Metastatic Hepatocellular Carcinoma (HCC)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Metastatic Hepatocellular Carcinoma (HCC), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Hepatocellular Carcinoma (HCC) and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from acr
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Visceral Pain - Pipeline Review, H1 2015
Global Markets Directs, Visceral Pain Pipeline Review, H1 2015, provides an overview of the Visceral Pains therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Visceral Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Visceral Pain and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and inform
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Glomerulonephritis - Pipeline Review, H1 2015
Global Markets Directs, Glomerulonephritis Pipeline Review, H1 2015, provides an overview of the Glomerulonephritiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Glomerulonephritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Glomerulonephritis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built u
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Medullary Thyroid Cancer - Pipeline Review, H1 2015
Global Markets Directs, Medullary Thyroid Cancer Pipeline Review, H1 2015, provides an overview of the Medullary Thyroid Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Medullary Thyroid Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Medullary Thyroid Cancer and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indication
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Aortic Aneurysm - Pipeline Review, H1 2015
Global Markets Directs, Aortic Aneurysm Pipeline Review, H1 2015, provides an overview of the Aortic Aneurysms therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Aortic Aneurysm, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Aortic Aneurysm and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data an
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Neuromyelitis Optica (Devics Syndrome) - Pipeline Review, H1 2015
Global Markets Directs, Neuromyelitis Optica (Devics Syndrome) Pipeline Review, H1 2015, provides an overview of the Neuromyelitis Optica (Devics Syndrome)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Neuromyelitis Optica (Devics Syndrome), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Neuromyelitis Optica (Devics Syndrome) and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe co
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Hemorrhage - Pipeline Review, H1 2015
Global Markets Directs, Hemorrhage Pipeline Review, H1 2015, provides an overview of the Hemorrhages therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hemorrhage, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hemorrhage and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information source
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Poxvirus Infections - Pipeline Review, H1 2015
Global Markets Directs, Poxvirus Infections Pipeline Review, H1 2015, provides an overview of the Poxvirus Infectionss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Poxvirus Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Poxvirus Infections and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is bui
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Liposarcoma - Pipeline Review, H1 2015
Global Markets Directs, Liposarcoma Pipeline Review, H1 2015, provides an overview of the Liposarcomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Liposarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Liposarcoma and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information so
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Heart Attack - Pipeline Review, H1 2015
Global Markets Directs, Heart Attack Pipeline Review, H1 2015, provides an overview of the Heart Attacks therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Heart Attack, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Heart Attack and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and informatio
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Diabetic Gastroparesis - Pipeline Review, H1 2015
Global Markets Directs, Diabetic Gastroparesis Pipeline Review, H1 2015, provides an overview of the Diabetic Gastroparesiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Diabetic Gastroparesis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diabetic Gastroparesis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The r
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Sarcoidosis - Pipeline Review, H1 2015
Global Markets Directs, Sarcoidosis Pipeline Review, H1 2015, provides an overview of the Sarcoidosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Sarcoidosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Sarcoidosis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information so
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Arenavirus Infection Lassa Fever - Pipeline Review, H1 2015
Global Markets Directs, Arenavirus Infection Lassa Fever Pipeline Review, H1 2015, provides an overview of the Arenavirus Infection Lassa Fevers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Arenavirus Infection Lassa Fever, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Arenavirus Infection Lassa Fever and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy a
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Hemorrhagic Shock - Pipeline Review, H1 2015
Global Markets Directs, Hemorrhagic Shock Pipeline Review, H1 2015, provides an overview of the Hemorrhagic Shocks therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hemorrhagic Shock, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hemorrhagic Shock and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Pre-Eclampsia - Pipeline Review, H1 2015
Pre-Eclampsia - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Pre-Eclampsia - Pipeline Review, H1 2015, provides an overview of the Pre-Eclampsias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Pre-Eclampsia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pre-Eclampsia and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Keloids - Pipeline Review, H1 2015
Keloids - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Keloids - Pipeline Review, H1 2015, provides an overview of the Keloidss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Keloids, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Keloids and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Gastric Ulcers - Pipeline Review, H1 2015
Gastric Ulcers - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Gastric Ulcers - Pipeline Review, H1 2015, provides an overview of the Gastric Ulcerss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Gastric Ulcers, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Gastric Ulcers and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications.
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Pemphigus - Pipeline Review, H1 2015
Pemphigus - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Pemphigus - Pipeline Review, H1 2015, provides an overview of the Pemphiguss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Pemphigus, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pemphigus and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built usin
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Bronchopulmonary Dysplasia - Pipeline Review, H1 2015
Bronchopulmonary Dysplasia - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Bronchopulmonary Dysplasia - Pipeline Review, H1 2015, provides an overview of the Bronchopulmonary Dysplasias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Bronchopulmonary Dysplasia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Bronchopulmonary Dysplasia and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Pituitary ACTH Hypersecretion (Cushings Disease) - Pipeline Review, H1 2015
Global Markets Directs, Pituitary ACTH Hypersecretion (Cushings Disease) Pipeline Review, H1 2015, provides an overview of the Pituitary ACTH Hypersecretion (Cushings Disease)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pituitary ACTH Hypersecretion (Cushings Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pituitary ACTH Hypersecretion (Cushings Disease) and special features on late-stage and discontinued projects. Global Markets Directs report features in
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Obesity - Pipeline Review, H1 2015
Global Markets Directs, Obesity Pipeline Review, H1 2015, provides an overview of the Obesitys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Obesity, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Obesity and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Globa
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Leukodystrophies - Pipeline Review, H1 2015
Global Markets Directs, Leukodystrophies Pipeline Review, H1 2015, provides an overview of the Leukodystrophiess therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Leukodystrophies, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Leukodystrophies and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using dat
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Spinal Stenosis - Pipeline Review, H1 2015
Global Markets Directs, Spinal Stenosis Pipeline Review, H1 2015, provides an overview of the Spinal Stenosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Spinal Stenosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Spinal Stenosis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data an
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Polycythemia Vera - Pipeline Review, H1 2015
Global Markets Directs, Polycythemia Vera Pipeline Review, H1 2015, provides an overview of the Polycythemia Veras therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Polycythemia Vera, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Polycythemia Vera and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Vulvovaginal Candidiasis - Pipeline Review, H1 2015
Global Markets Directs, Vulvovaginal Candidiasis Pipeline Review, H1 2015, provides an overview of the Vulvovaginal Candidiasiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Vulvovaginal Candidiasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Vulvovaginal Candidiasis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indication
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Muscle Atrophy - Pipeline Review, H1 2015
Global Markets Directs, Muscle Atrophy Pipeline Review, H1 2015, provides an overview of the Muscle Atrophys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Muscle Atrophy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Muscle Atrophy and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and in
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Viral Conjunctivitis - Pipeline Review, H1 2015
Global Markets Directs, Viral Conjunctivitis Pipeline Review, H1 2015, provides an overview of the Viral Conjunctivitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Viral Conjunctivitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Viral Conjunctivitis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Edema - Pipeline Review, H1 2015
Global Markets Directs, Edema Pipeline Review, H1 2015, provides an overview of the Edemas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Edema, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Edema and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Market
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Trigeminal Neuralgia - Pipeline Review, H1 2015
Trigeminal Neuralgia - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Trigeminal Neuralgia - Pipeline Review, H1 2015, provides an overview of the Trigeminal Neuralgias therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Trigeminal Neuralgia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Trigeminal Neuralgia and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Gastroparesis - Pipeline Review, H1 2015
Global Markets Directs, Gastroparesis Pipeline Review, H1 2015, provides an overview of the Gastroparesiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Gastroparesis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Gastroparesis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and inform
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H1 2015
Global Markets Directs, Acquired (Autoimmune) Hemolytic Anemia Pipeline Review, H1 2015, provides an overview of the Acquired (Autoimmune) Hemolytic Anemias therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Acquired (Autoimmune) Hemolytic Anemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acquired (Autoimmune) Hemolytic Anemia and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe co
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Lipodystrophy - Pipeline Review, H1 2015
Global Markets Directs, Lipodystrophy Pipeline Review, H1 2015, provides an overview of the Lipodystrophys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Lipodystrophy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Lipodystrophy and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and inform
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Myocarditis - Pipeline Review, H1 2015
Global Markets Directs, Myocarditis Pipeline Review, H1 2015, provides an overview of the Myocarditiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Myocarditis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Myocarditis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information so
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Western Equine Encephalitis - Pipeline Review, H1 2015
Global Markets Directs, Western Equine Encephalitis Pipeline Review, H1 2015, provides an overview of the Western Equine Encephalitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Western Equine Encephalitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Western Equine Encephalitis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,00
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Batten Disease - Pipeline Review, H1 2015
Global Markets Directs, Batten Disease Pipeline Review, H1 2015, provides an overview of the Batten Diseases therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Batten Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Batten Disease and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and in
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Hyper Pigmentation - Pipeline Review, H1 2015
Global Markets Directs, Hyper Pigmentation Pipeline Review, H1 2015, provides an overview of the Hyper Pigmentations therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hyper Pigmentation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hyper Pigmentation and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built u
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Exocrine Pancreatic Insufficiency - Pipeline Review, H1 2015
Global Markets Directs, Exocrine Pancreatic Insufficiency Pipeline Review, H1 2015, provides an overview of the Exocrine Pancreatic Insufficiencys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Exocrine Pancreatic Insufficiency, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Exocrine Pancreatic Insufficiency and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 thera
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Cat Allergy - Pipeline Review, H1 2015
Global Markets Directs, Cat Allergy Pipeline Review, H1 2015, provides an overview of the Cat Allergys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cat Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cat Allergy and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information so
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Oropharyngeal Candidiasis - Pipeline Review, H1 2015
Global Markets Directs, Oropharyngeal Candidiasis Pipeline Review, H1 2015, provides an overview of the Oropharyngeal Candidiasiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Oropharyngeal Candidiasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Oropharyngeal Candidiasis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indica
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Hypogonadotropic Hypogonadism - Pipeline Review, H1 2015
Global Markets Directs, Hypogonadotropic Hypogonadism Pipeline Review, H1 2015, provides an overview of the Hypogonadotropic Hypogonadisms therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hypogonadotropic Hypogonadism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hypogonadotropic Hypogonadism and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nea
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Acute Lymphoblastic Lymphoma - Pipeline Review, H1 2015
Acute Lymphoblastic Lymphoma - Pipeline Review, H1 2015SummaryGlobal Markets Directs, Acute Lymphoblastic Lymphoma - Pipeline Review, H1 2015, provides an overview of the Acute Lymphoblastic Lymphomas therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Acute Lymphoblastic Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acute Lymphoblastic Lymphoma and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from acr
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Anal Cancer - Pipeline Review, H1 2015
Global Markets Directs, Anal Cancer Pipeline Review, H1 2015, provides an overview of the Anal Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Anal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Anal Cancer and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information so
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Lebers Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Pipeline Review, H1 2015
Global Markets Directs, Lebers Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) Pipeline Review, H1 2015, provides an overview of the Lebers Hereditary Optic Neuropathy (LHON) (Leber optic atrophy)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Lebers Hereditary Optic Neuropathy (LHON) (Leber optic atrophy), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Lebers Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) and special features on late-stage and discont
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Type 2 Diabetes - Pipeline Review, H1 2015
Global Markets Directs, Type 2 Diabetes - Pipeline Review, H1 2015, provides an overview of the Type 2 Diabetess therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Type 2 Diabetes, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Type 2 Diabetes and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2500
Chronic Pain - Pipeline Review, H1 2015
Global Markets Directs, Chronic Pain - Pipeline Review, H1 2015, provides an overview of the Chronic Pains therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chronic Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chronic Pain and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and informat
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Anxiety Disorders - Pipeline Review, H1 2015
Global Markets Directs, Anxiety Disorders - Pipeline Review, H1 2015, provides an overview of the Anxiety Disorderss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Anxiety Disorders, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Anxiety Disorders and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built usi
Published Date: Feb 2015
Published By: Global Markets Direct

Price: $2000
Idiopathic Short Stature - Pipeline Review, H1 2015
Global Markets Directs, Idiopathic Short Stature Pipeline Review, H1 2015, provides an overview of the Idiopathic Short Statures therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Idiopathic Short Stature, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Idiopathic Short Stature and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indication
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Cholera - Pipeline Review, H1 2015
Global Markets Directs, Cholera Pipeline Review, H1 2015, provides an overview of the Choleras therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cholera, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cholera and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Globa
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Mumps - Pipeline Review, H1 2015
Global Markets Directs, Mumps Pipeline Review, H1 2015, provides an overview of the Mumpss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Mumps, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Mumps and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Market
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Xerostomia - Pipeline Review, H1 2015
Global Markets Directs, Xerostomia Pipeline Review, H1 2015, provides an overview of the Xerostomias therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Xerostomia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Xerostomia and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information source
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Metastatic Biliary Tract Cancer - Pipeline Review, H1 2015
Global Markets Directs, Metastatic Biliary Tract Cancer Pipeline Review, H1 2015, provides an overview of the Metastatic Biliary Tract Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Metastatic Biliary Tract Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Biliary Tract Cancer and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Fibrosarcoma - Pipeline Review, H1 2015
Global Markets Directs, Fibrosarcoma Pipeline Review, H1 2015, provides an overview of the Fibrosarcomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Fibrosarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Fibrosarcoma and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and informatio
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Anterior Uveitis - Pipeline Review, H1 2015
Global Markets Directs, Anterior Uveitis Pipeline Review, H1 2015, provides an overview of the Anterior Uveitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Anterior Uveitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Anterior Uveitis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using dat
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Gastrointestinal Radiation Toxicity - Pipeline Review, H1 2015
Global Markets Directs, Gastrointestinal Radiation Toxicity Pipeline Review, H1 2015, provides an overview of the Gastrointestinal Radiation Toxicitys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Gastrointestinal Radiation Toxicity, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Gastrointestinal Radiation Toxicity and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Premature Labor (Tocolysis) - Pipeline Review, H1 2015
Global Markets Directs, Premature Labor (Tocolysis) Pipeline Review, H1 2015, provides an overview of the Premature Labor (Tocolysis)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Premature Labor (Tocolysis), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Premature Labor (Tocolysis) and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,00
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Male Hypogonadism - Pipeline Review, H1 2015
Global Markets Directs, Male Hypogonadism Pipeline Review, H1 2015, provides an overview of the Male Hypogonadisms therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Male Hypogonadism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Male Hypogonadism and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Head And Neck Cancer - Pipeline Review, H1 2015
Global Markets Directs, Head And Neck Cancer Pipeline Review, H1 2015, provides an overview of the Head And Neck Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Head And Neck Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Head And Neck Cancer and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Depression - Pipeline Review, H1 2015
Global Markets Directs, Depression Pipeline Review, H1 2015, provides an overview of the Depressions therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Depression, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Depression and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information source
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015
Global Markets Directs, Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Pipeline Review, H1 2015, provides an overview of the Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hormone Refractory (Castration Resistant, Androgen-Independent
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Metastatic Melanoma - Pipeline Review, H1 2015
Global Markets Directs, Metastatic Melanoma Pipeline Review, H1 2015, provides an overview of the Metastatic Melanomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Metastatic Melanoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Melanoma and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is bui
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Epilepsy - Pipeline Review, H1 2015
Global Markets Directs, Epilepsy Pipeline Review, H1 2015, provides an overview of the Epilepsys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Epilepsy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Epilepsy and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from G
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2015
Global Markets Directs, Congestive Heart Failure (Heart Failure) Pipeline Review, H1 2015, provides an overview of the Congestive Heart Failure (Heart Failure)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Congestive Heart Failure (Heart Failure), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Congestive Heart Failure (Heart Failure) and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Hyperlipidemia - Pipeline Review, H1 2015
Global Markets Directs, Hyperlipidemia Pipeline Review, H1 2015, provides an overview of the Hyperlipidemias therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hyperlipidemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hyperlipidemia and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and in
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Alcohol Addiction - Pipeline Review, H1 2015
Global Markets Directs, Alcohol Addiction Pipeline Review, H1 2015, provides an overview of the Alcohol Addictions therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Alcohol Addiction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Alcohol Addiction and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Urinary Tract Infections - Pipeline Review, H1 2015
ipeline Review, H1 2015SummaryGlobal Markets Directs, Urinary Tract Infections - Pipeline Review, H1 2015, provides an overview of the Urinary Tract Infectionss therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Urinary Tract Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Urinary Tract Infections and special features on late-stage and discontinued projects.Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nea
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2015
Global Markets Directs, Human papillomavirus (HPV) Associated Cancer Pipeline Review, H1 2015, provides an overview of the Human papillomavirus (HPV) Associated Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Human papillomavirus (HPV) Associated Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Human papillomavirus (HPV) Associated Cancer and special features on late-stage and discontinued projects. Global Markets Directs report features investigational dr
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2015
Global Markets Directs, Systemic Sclerosis (Scleroderma) Pipeline Review, H1 2015, provides an overview of the Systemic Sclerosis (Scleroderma)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Systemic Sclerosis (Scleroderma), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Systemic Sclerosis (Scleroderma) and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy a
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Colitis - Pipeline Review, H1 2015
Global Markets Directs, Colitis Pipeline Review, H1 2015, provides an overview of the Colitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Colitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Colitis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Globa
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Alopecia - Pipeline Review, H1 2015
Global Markets Direct’s, ‘Alopecia Pipeline Review, H1 2015’, provides an overview of the Alopecia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Alopecia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Alopecia and special features on late-stage and discontinued projects. Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Moderate Pain - Pipeline Review, H1 2015
Global Markets Directs, Moderate Pain Pipeline Review, H1 2015, provides an overview of the Moderate Pains therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Moderate Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Moderate Pain and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and inform
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Cancer Cachexia - Pipeline Review, H1 2015
Global Markets Directs, Cancer Cachexia Pipeline Review, H1 2015, provides an overview of the Cancer Cachexias therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cancer Cachexia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cancer Cachexia and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data an
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Memory Impairment - Pipeline Review, H1 2015
Global Markets Directs, Memory Impairment Pipeline Review, H1 2015, provides an overview of the Memory Impairments therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Memory Impairment, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Memory Impairment and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2015
Global Markets Directs, Metastatic Adenocarcinoma of The Pancreas Pipeline Review, H1 2015, provides an overview of the Metastatic Adenocarcinoma of The Pancreass therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Metastatic Adenocarcinoma of The Pancreas, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Adenocarcinoma of The Pancreas and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from acr
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Myelofibrosis - Pipeline Review, H1 2015
Global Markets Directs, Myelofibrosis Pipeline Review, H1 2015, provides an overview of the Myelofibrosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Myelofibrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Myelofibrosis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and inform
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Smoking Cessation - Pipeline Review, H1 2015
Global Markets Directs, Smoking Cessation Pipeline Review, H1 2015, provides an overview of the Smoking Cessations therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Smoking Cessation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Smoking Cessation and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015
Global Markets Directs, Squamous Non-Small Cell Lung Cancer Pipeline Review, H1 2015, provides an overview of the Squamous Non-Small Cell Lung Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Squamous Non-Small Cell Lung Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Squamous Non-Small Cell Lung Cancer and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Indolent Lymphoma - Pipeline Review, H1 2015
Global Markets Directs, Indolent Lymphoma Pipeline Review, H1 2015, provides an overview of the Indolent Lymphomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Indolent Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Indolent Lymphoma and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Hospital Acquired Pneumonia (HAP) - Pipeline Review, H1 2015
Global Markets Directs, Hospital Acquired Pneumonia (HAP) Pipeline Review, H1 2015, provides an overview of the Hospital Acquired Pneumonia (HAP)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hospital Acquired Pneumonia (HAP), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hospital Acquired Pneumonia (HAP) and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 thera
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Open-Angle Glaucoma - Pipeline Review, H1 2015
Global Markets Directs, Open-Angle Glaucoma Pipeline Review, H1 2015, provides an overview of the Open-Angle Glaucomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Open-Angle Glaucoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Open-Angle Glaucoma and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is bui
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H1 2015
Global Markets Directs, Reflux Esophagitis (Gastroesophageal Reflux Disease) Pipeline Review, H1 2015, provides an overview of the Reflux Esophagitis (Gastroesophageal Reflux Disease)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Reflux Esophagitis (Gastroesophageal Reflux Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Reflux Esophagitis (Gastroesophageal Reflux Disease) and special features on late-stage and discontinued projects. Global Markets Directs re
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Plague - Pipeline Review, H1 2015
Global Markets Directs, Plague Pipeline Review, H1 2015, provides an overview of the Plagues therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Plague, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Plague and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Ma
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Gauchers Disease - Pipeline Review, H1 2015
Global Markets Directs, Gaucher's Disease Pipeline Review, H1 2015, provides an overview of the Gaucher's Diseases therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Gaucher's Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Gaucher's Disease and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2015
Global Markets Directs, B-Cell Chronic Lymphocytic Leukemia Pipeline Review, H1 2015, provides an overview of the B-Cell Chronic Lymphocytic Leukemias therapeutic pipeline. This report provides comprehensive information on the therapeutic development for B-Cell Chronic Lymphocytic Leukemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for B-Cell Chronic Lymphocytic Leukemia and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Degenerative Disc Disease - Pipeline Review, H1 2015
Global Markets Directs, Degenerative Disc Disease Pipeline Review, H1 2015, provides an overview of the Degenerative Disc Diseases therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Degenerative Disc Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Degenerative Disc Disease and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indica
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Smallpox - Pipeline Review, H1 2015
Global Markets Directs, Smallpox Pipeline Review, H1 2015, provides an overview of the Smallpoxs therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Smallpox, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Smallpox and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from G
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Epstein-Barr Viral Infections - Pipeline Review, H1 2015
Global Markets Directs, Epstein-Barr Viral Infections Pipeline Review, H1 2015, provides an overview of the Epstein-Barr Viral Infectionss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Epstein-Barr Viral Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Epstein-Barr Viral Infections and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nea
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Chemotherapy Induced Nausea and Vomiting - Pipeline Review, H1 2015
Global Markets Directs, Chemotherapy Induced Nausea and Vomiting Pipeline Review, H1 2015, provides an overview of the Chemotherapy Induced Nausea and Vomitings therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chemotherapy Induced Nausea and Vomiting, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chemotherapy Induced Nausea and Vomiting and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Vasculitis - Pipeline Review, H1 2015
Global Markets Directs, Vasculitis Pipeline Review, H1 2015, provides an overview of the Vasculitiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Vasculitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Vasculitis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information source
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000
Secondary Hyperparathyroidism - Pipeline Review, H1 2015
Global Markets Directs, Secondary Hyperparathyroidism Pipeline Review, H1 2015, provides an overview of the Secondary Hyperparathyroidisms therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Secondary Hyperparathyroidism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Secondary Hyperparathyroidism and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nea
Published Date: Jan 2015
Published By: Global Markets Direct

Price: $2000